Michael Torgov
- Oncology top 2%
- Radiology, Nuclear Medicine and Imaging top 1%
- Molecular Biology
- Organic Chemistry top 10%
- Immunology
- Co-authors
- Peter D. SenterCharles G. CervenyBrian A. MendelsohnSvetlana O. DoroninaDamon L. MeyerClay B. SiegallTim D. BoveeBrian E. Toki
- Topics
- Monoclonal and Polyclonal Antibodies Research (10 papers)Radiopharmaceutical Chemistry and Applications (5 papers)HER2/EGFR in Cancer Research (5 papers)
- Partner nations
- United StatesNew ZealandJapan
In The Last Decade
Michael Torgov
18 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 83
- Oncology 983
- Radiology, Nuclear Medicine and Imaging 941
- Molecular Biology 639
- Organic Chemistry 167
- Immunology 136
Countries citing papers authored by Michael Torgov
This map shows the geographic impact of Michael Torgov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Torgov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Torgov more than expected).
Fields of papers citing papers by Michael Torgov
This network shows the impact of papers produced by Michael Torgov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Torgov. The network helps show where Michael Torgov may publish in the future.
Co-authorship network of co-authors of Michael Torgov
This figure shows the co-authorship network connecting the top 25 collaborators of Michael Torgov. A scholar is included among the top collaborators of Michael Torgov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Torgov. Michael Torgov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 18 | |
| 3 | 13 | |
| 4 | 5 | |
| 5 | 10 | |
| 6 | 1 | |
| 7 | 2 | |
| 8 | 6 | |
| 9 | 47 | |
| 10 | 58 | |
| 11 | 76 | |
| 12 | 10 | |
| 13 | 294 | |
| 14 | 65 | |
| 15 | 44 | |
| 16 | Development of potent monoclonal antibody auristatin conjugates for cancer therapybreakdown → | 903 |
| 17 | 3 | |
| 18 | 3 | |
| 19 | 9 |
About Michael Torgov
Michael Torgov is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Immunology and Allergy, having authored 19 papers that have together received 1.6k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (10 papers), Radiopharmaceutical Chemistry and Applications (5 papers) and HER2/EGFR in Cancer Research (5 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (941 citations), Oncology (983 citations) and Immunology and Allergy (93 citations). Michael Torgov has collaborated with scholars based in United States, New Zealand and Japan. Frequent co-authors include Peter D. Senter, Charles G. Cerveny, Brian A. Mendelsohn, Svetlana O. Doronina, Damon L. Meyer, Clay B. Siegall, Tim D. Bovee, Brian E. Toki, Alan F. Wahl and Dana F. Chace. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Nature Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.